Douglas Cliff/iStock Editorial via Getty Images
Novo Holdings won European Union antitrust approval for its planned $16.5 billion purchase of Catalent (NYSE:CTLT).
The deal is expected to close towards the end of calendar year 2024, subject to the satisfaction of other customary closing conditions, including receipt of all
